Exact Sciences Corporation logo
Exact Sciences Corporation EXAS
$ 103.37 0.02%

Quarterly report 2025-Q3
added 11-03-2025

report update icon

Exact Sciences Corporation Income Statement 2011-2026 | EXAS

Annual Income Statement Exact Sciences Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

9.32 B 11.3 B 10.9 B 13.1 B 20.7 B 12.3 B 10.7 B 5.73 B 1.85 B 605 M 2.18 B 902 M 644 M 478 M

Shares

185 M 181 M 176 M 171 M 151 M 131 M 122 M 116 M 102 M 92.1 M 80.2 M 67.5 M 59.5 M 52.5 M

Historical Prices

50.3 62.3 61.8 76.4 137 93.3 90.1 49.7 18.9 6.57 27.2 13 11 9.34

Net Income

-865 M -49.8 M -624 M -596 M -824 M -84 M -175 M -114 M -167 M -158 M -100 M -46.5 M -52.5 M -28.7 M

Revenue

2.76 B 2.5 B 2.08 B 1.77 B 1.49 B 876 M 454 M 266 M 99.4 M 39.4 M 1.8 M 4.14 M 4.14 M 4.16 M

Cost of Revenue

221 M 193 M 661 M 459 M 354 M 217 M 117 M 78.3 M 45.2 M 24.5 M 4.32 M - - 24 K

Gross Profit

493 M 454 M 1.42 B - - 660 M 336 M 187 M 54.2 M 14.9 M -2.53 M 4.14 M 4.14 M 4.14 M

Operating Income

-876 M -67.8 M -594 M -856 M -768 M -234 M -159 M -118 M -169 M -159 M -101 M -46.8 M -52.6 M -28.8 M

Interest Expense

- - - 18.6 M 67.9 M 199 M 36.8 M 206 K -213 K 6 K 51 K 69 K 41 K 21 K

EBITDA

-757 M 46.6 M -493 M -761 M -698 M -218 M -136 M -103 M -157 M -155 M -98.9 M -45.3 M -51.7 M -28.4 M

Operating Expenses

2.98 B 2.06 B 2 B - - 893 M 496 M 305 M 223 M 174 M 98 M 50.9 M 56.8 M 33 M

General and Administrative Expenses

191 M 196 M 663 M 801 M 481 M 540 M 296 M 186 M 138 M 106 M 65.2 M 22.7 M 14.4 M 8.14 M

All numbers in USD currency

Quarterly Income Statement Exact Sciences Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

189 M 189 M 187 M 186 M 185 M 184 M 182 M 181 M 181 M 180 M 179 M 178 M 177 M 176 M 174 M 174 M 172 M 171 M 169 M 156 M 150 M 150 M 148 M 140 M 130 M 129 M 126 M 123 M 123 M 122 M 121 M 120 M 119 M 113 M 111 M 109 M 105 M 97.9 M 97.2 M 96.4 M 94.4 M 88.9 M 88.7 M 84.7 M 82.9 M 82 M 71 M 70.8 M 70.6 M 64.7 M 63.8 M 63.6 M 60.5 M 57 M 56.7 M 53.6 M 52.4 M 52 M 51.9 M

Net Income

-19.6 M -1.18 M -101 M - -38.2 M -15.8 M -110 M - 794 K -81 M -74.2 M - -149 M -166 M -181 M -221 M -167 M -177 M -31.2 M -418 M -203 M -68.1 M -135 M 78 M -40.5 M -38.5 M -82.9 M -54 M -45.4 M -36.4 M -39.4 M -21.8 M -26.9 M -30.8 M -34.9 M -37.2 M -37.8 M -44.8 M -47.5 M -40 M -42.9 M -39.1 M -35.8 M -32.4 M -32.1 M -19.4 M -16.1 M -12.2 M -11.2 M -12.3 M -10.9 M -14 M -13 M -14.8 M -10.6 M -9.9 M -7.77 M -6.62 M -4.37 M

Revenue

851 M 811 M 707 M - 709 M 699 M 638 M - 628 M 622 M 602 M - 523 M 522 M 487 M 474 M 456 M 435 M 402 M 466 M 408 M 269 M 348 M 296 M 219 M 200 M 162 M 143 M 118 M 103 M 90.3 M 87.4 M 72.6 M 57.6 M 48.4 M - - - - - 12.6 M 8.12 M 4.27 M - 294 K 294 K 294 K 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M

Cost of Revenue

267 M 249 M 206 M - 217 M 211 M 191 M - 169 M 157 M 157 M - 148 M 145 M 135 M 119 M 116 M 114 M 110 M 99.8 M 95.1 M 77.9 M 81.6 M 70.4 M 52.3 M 51.1 M 42.8 M 37.8 M 29.7 M 26.6 M 22.6 M 23.5 M 20.7 M 18 M 17 M 13.9 M 12.2 M 10.1 M 9.06 M 7.67 M 7.53 M 5.09 M 4.21 M 3.4 M 924 K - - - - - - - - - - 6 K 6 K 6 K 6 K

Gross Profit

584 M 562 M 501 M - 491 M 488 M 446 M - - - - - - - - 334 M 319 M 300 M 272 M 346 M 293 M 170 M 246 M 213 M 166 M 148 M 119 M 105 M 88.3 M 76 M 67.4 M 63.9 M 51.8 M 39.7 M 31.4 M 21.4 M 15.9 M 11.1 M 5.78 M 6.75 M 5.1 M 3.02 M 54 K -1.9 M -924 K 294 K 294 K 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.04 M 1.03 M 1.04 M 1.03 M

Operating Income

-25.5 M -2.15 M -96 M - -39.4 M -26.3 M -107 M - 6.85 M -76.9 M -77.1 M - -138 M -160 M -177 M - -162 M -172 M -301 M - -203 M -67 M -82.4 M -96.1 M -35.7 M -33.9 M -68.1 M -49.3 M -40.9 M -32.7 M -36.5 M -23 M -28.4 M -31.4 M -35.5 M -37.7 M -38.3 M -45.1 M -47.9 M -40.4 M -43.3 M -39.4 M -36 M -32.6 M -32.2 M -19.6 M -16.2 M -12.3 M -11.2 M -12.4 M -10.9 M -14 M -13 M -14.9 M -10.7 M -9.94 M -7.84 M -6.64 M -4.4 M

Interest Expense

- - - - -9.61 M 111 K -7.94 M - -7.87 M -7.82 M 4.11 M - -5.24 M -4.51 M -4.48 M - -4.68 M -4.65 M -4.62 M - 23.6 M 22.9 M 25.2 M -13.7 M 13.2 M 12.7 M 22 M -11 M 10.7 M 8.6 M -6.51 M -51 K -51 K -54 K -50 K -52 K -54 K -53 K 54 K -62 K -40 K 107 K 11 K 11 K 12 K 13 K 15 K 16 K 16 K 18 K 19 K 20 K 11 K 5 K 5 K 6 K 5 K 5 K 5 K

EBITDA

6.16 M 29 M -66 M - -9.1 M 3.44 M -76.1 M - 36.1 M -49.4 M -50.3 M - -113 M -134 M -154 M - -140 M -150 M -280 M - -150 M -33.4 M -66.4 M -82.3 M -13.8 M -20.4 M -61.7 M -48.6 M -26.6 M -23.9 M -32.2 M -23 M -27.8 M -31.1 M -35.4 M -37.7 M -38.1 M -45 M -45.4 M -40.4 M -43.3 M -39.4 M -34.4 M -32.6 M -29.9 M -18.2 M -15.5 M -12.3 M -10.3 M -11.7 M -10.6 M -14 M -12.3 M -14.5 M -10.5 M -9.94 M -7.58 M -6.5 M -4.34 M

Operating Expenses

609 M 565 M 597 M - 534 M 518 M 553 M - - - - - - - - 555 M 481 M 471 M 572 M 761 M 496 M 237 M 328 M 309 M 202 M 182 M 187 M - 129 M 109 M 104 M - 80.3 M 71.1 M 66.9 M - 54.2 M 56.2 M 53.7 M - 48.4 M 42.4 M 36.1 M - 31.3 M 19.6 M 16.5 M - 12.3 M 13.4 M 11.9 M - 14 M 15.9 M 11.7 M - 8.88 M 7.68 M 5.44 M

General and Administrative Expenses

241 M 209 M 221 M - 194 M 178 M 220 M - 217 M 238 M 217 M - 192 M 182 M 170 M - 187 M 168 M 268 M - 116 M 107 M 114 M 144 M 80.5 M 63.7 M 63.8 M 56.3 M 46.7 M 39.5 M 35.5 M 33.6 M 30.8 M 24.6 M 20.1 M 21.5 M 20.3 M 17.3 M 17.8 M 15.9 M 15.4 M 13.7 M 13 M 10.6 M 8.99 M 6.23 M 4.59 M 3.69 M 3.69 M 3.63 M 2.65 M 2.82 M 2.55 M 2.39 M 2.14 M 2.21 M 1.95 M 1.83 M 2.15 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Exact Sciences Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Anixa Biosciences Anixa Biosciences
ANIX
$ 2.81 -5.39 % $ 91.2 K usaUSA
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 23.0 -1.5 % $ 99.4 M israelIsrael
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 28.5 -8.06 % $ 307 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
Co-Diagnostics Co-Diagnostics
CODX
- - $ 79.8 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.13 -3.26 % $ 1.44 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Castle Biosciences Castle Biosciences
CSTL
$ 32.44 0.22 % $ 901 M usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 218.83 -0.41 % $ 160 B usaUSA
Celcuity Celcuity
CELC
$ 101.7 -2.37 % $ 4.01 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 206.95 0.83 % $ 23 B usaUSA
DexCom DexCom
DXCM
$ 68.33 0.24 % $ 26.4 B usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 19.43 -5.57 % $ 1.04 B usaUSA
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 10.4 -4.76 % $ 295 M israelIsrael
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
$ 1.82 - $ 7.98 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 22.74 -1.41 % $ 688 M usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 66.24 -1.39 % $ 4.58 B usaUSA
Guardant Health Guardant Health
GH
$ 104.16 -0.83 % $ 12.8 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 400.6 0.04 % $ 28.9 B schweizSchweiz
NeoGenomics NeoGenomics
NEO
$ 11.36 -1.26 % $ 1.44 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Natera Natera
NTRA
$ 206.93 -2.23 % $ 20.4 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 165.55 -8.67 % $ 8.51 B usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 645.07 -0.23 % $ 53.2 B usaUSA
Illumina Illumina
ILMN
$ 117.29 -1.7 % $ 18.6 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 177.19 -2.89 % $ 32.1 B usaUSA
OPKO Health OPKO Health
OPK
$ 1.23 0.86 % $ 854 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 31.87 -3.2 % $ 20 B niderlandNiderland
Biodesix Biodesix
BDSX
$ 10.18 -2.12 % $ 1.32 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 286.87 0.86 % $ 24.1 B usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
$ 3.7 -0.77 % $ 1.99 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 131.48 -9.05 % $ 10.8 B irlandaIrlanda
Quidel Corporation Quidel Corporation
QDEL
$ 27.58 -5.6 % $ 1.16 B usaUSA
Biomerica Biomerica
BMRA
$ 2.23 -3.88 % $ 5.12 M usaUSA